Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 1984 · 13 citations · 12 references
MedicineBiochemistryInternal MedicineClinical BiochemistryHepatic PharmacotherapyHepatologyBile Acid MetabolismHepatic Function TestingHepatic ImpairmentLiver DiseaseLiver Function Tests3 Alpha-hydroxysteroid Dehydrogenase3 Beta-hydroxysteroid DehydrogenaseCholestatic JaundiceContinuous FlowRifampicin TherapySerum Bile AcidSerum Bile Acids TestingSerum Bilirubin Testing
Serum bile acid levels in 61 patients receiving daily doses of rifampicin and isoniazid for the treatment of tuberculosis have been investigated. Bile acids were measured using 3 alpha-hydroxysteroid dehydrogenase in a continuous-flow system. Abnormally elevated levels were found in 44 patients (72%) during the period of study up to 80 days after onset of treatment. The results showed a mean of 24.9 mumol/l and a positively skewed distribution. Whilst marginally raised levels of bilirubin were seen in some samples (mean 8.2 mumol/l), these did not reflect the marked changes observed in bile acids. Patients receiving rifampicin and isoniazid may therefore have markedly elevated levels of total serum bile acids, while other tests used to assess liver function can remain normal.
12
Richard J. Henry, Neil Chiamori, Orville J. Golub et al. · American Journal of Clinical Pathology · 1960 · 690 citations
Isoniazid-Associated Hepatitis
Richard A. Garibaldi, Ronald Drusin, Shirley H. Ferebee et al. · American Review of Respiratory Disease · 1972 · 238 citations
Willis C. Maddrey · Annals of Internal Medicine · 1973 · 176 citations